Skip to content
CAS 107868-30-4 Chemical Raw Powder Aromasin Exemestane For Aging And Cancer
Aromasin Dosages and cycles:
In a therapeutic setting to treat breast cancer, Aromasin is only used after Nolvadex has failed. This is normally after 2-3 years of Nolvadex therapy. From here Aromasin is given to the patient at a dose of 25mg per day, which will normally last another 2-3 years or until the cancer’s progression has come to a halt. This is normally followed by more Nolvadex therapy in an effort to halt the cancer from returning. This is a highly successful plan in the fight against breast cancer.
In a performance setting, standard Aromasin doses will normally be 12.5-25mg every other day. Most should be fine with 12.5mg every other day, with some getting by with only two to three doses per week. The individual’s total sensitivity and the composition of the steroid in cycle in question will dictate the final outcome. There will be, however, some who require a daily dose with as much as 25mg per day. This should be short lived and only continued as long as necessary due to the possible cholesterol issues. This type of use can prove very useful for the competitive bodybuilder 7-14 days leading up to the completion in an effort to come in as dry and hard as possible. But again, this full dose use is only used for a limited time.
Aromasin Functions & Traits:
Aromasin is officially classified as a steroidal suicide Aromatase Inhibitor, and carries the ability to inhibit the aromatase enzyme, which is responsible for the production or conversion of testosterone to estrogen. Aromasin has the ability to block aromatization, which in turn inhibits the production of estrogen, and thereby lowers the body’s serum estrogen levels. This will prove useful to breast cancer patients as breast cancer often feeds off the estrogen hormone. It will also prove useful to the anabolic steroid user.
Many anabolic steroids have the ability to increase estrogen levels due to the aromatase process, specifically the conversion of testosterone to estrogen. This can lead to gynecomastia and water retention. Excess water retention can also promote high blood pressure when it becomes severe. Steroids that do not carry a strong estrogenic nature can also cause these effects, most notably gynecomastia if they carry a progestin nature. A prime example would be Nandrolone, which while it aromatizes only does so at 20% the rate of testosterone. However, it also carries a strong progestin nature, and progesterone has been well noted for carrying the ability to stimulate the estrogenic mechanism in the mammary tissue. By administering Aromasin during the use of anabolic steroids, this will inhibit the aromatase process, lower estrogen levels and protect the individual from estrogenic side effects. How effective is Aromasin? The product claims on average to have the ability to lower serum estrogen levels by 85%.
Aromasin also has the ability to stimulate natural testosterone production, which is precisely why some will include it during their PCT. Like Arimidex and Letrozole, Aromasin will stimulate the pituitary to release more Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH), two hormones essential to natural testosterone production. While the other common AI’s share this trait, Aromasin has been shown to carry a slight androgenic effect, as well as the ability to increase the production of Insulin-Like Growth Factor-1 (IGF-1). This is a trait no other AI can claim to carry. By using Aromasin during PCT, the individual receives the desired testosterone boost necessary for recovery, but with the IGF-1 increase also creates a stronger anabolic atmosphere. This is deemed useful by some steroid users as it could potentially give them the ability to protect their lean tissue all the more during use. However, when we look at the direct effects of Aromasin as it pertains to PCT, we will find PCT use is normally not recommended despite these positive effects.
What is Aromasin?
Aromasin (exemestane) lowers estrogen levels in postmenopausal women, which may slow the growth of certain types of breast tumors that need estrogen to grow in the body.
Aromasin is used to treat breast cancer in postmenopausal women. It is often given to women whose cancer has progressed even after surgery, radiation, or other cancer medications have been tried without success.
Aromasin may also be used for purposes not listed in this medication guide.
You should not use Aromasin if you are allergic to exemestane, if you have not started menopause, or if you are pregnant or able to become pregnant.
Do not use Aromasin if you are pregnant. It could harm the unborn baby.
Before taking this medicine
You should not use Aromasin if you are allergic to exemestane, or:
if you are pregnant or able to become pregnant; or
if you have not yet completed menopause, and are still having menstrual periods.
To make sure Aromasin is safe for you, tell your doctor if you have:
liver disease or kidney disease.
Aromasin can decrease bone mineral density, which may increase your risk of developing osteoporosis. Talk to your doctor about your individual risk of bone loss.
Although it is not likely that a postmenopausal woman would be pregnant, exemestane can cause birth defects. Do not take this medicine if you are pregnant or may become pregnant. You may need to have a negative pregnancy test before starting this treatment.
If you are not past menopause, use effective birth control to prevent pregnancy while you are taking Aromasin and for at least 1 month after your last dose. Tell your doctor right away if you become pregnant while taking Aromasin.
It is not known whether exemestane passes into breast milk or if it could harm a nursing baby. You should not breast-feed while using this medicine.
our other anti-estrogen powders: